American Xyrofin, a manufacturer of food additives, was sold, merged, and reorganized early in 1996, with predictable consequences for some of its executives. Cultor U.S. Inc. acquired Xyrofin in January 1996 and renamed the new subsidiary Cultor Food Science (cfs). Soon Cultor Limited (the parent of Cultor U.S.) bought another food additives group from Pfizer, Inc., and merged this business into cfs. As part of the acquisition, Cultor promised Pfizer that it would give Pfizer employees who joined cfs but later lost their jobs benefits tracking those of the severance-payment plan that Pfizer maintained under the Employee Retirement Income Security Act (erisa). When in March 1996 cfs ended the employment of Violeta Velasco, who came from Xyrofin (which lacked a severance-benefit plan), it offered her a severance package: six weeks’ pay, plus one additional week’s pay for each year she had been employed by Xyrofin, both doubled if she signed a release of any legal claims against cfs. Toward the end of March cfs decided that the services of Kenneth Sandstrom, Velasco’s supervisor, also were no longer necessary. Sand-strom, unlike Velasco, was not offered a severance package. He filed this suit under § 502(a)(1)(B) of erisa, 29 U.S.C. § 1132(a)(1)(B), contending that the offer to Velasco demonstrated that cfs had an “informal plan for severance benefits” that applied to him too. The district court disagreed and granted summary judgment for cfs. 1999 U.S. Dist. Lexis 6525 (N.D.Ill. Apr. 26, 1999).
Briefs filed in this court dwell on two questions: whether Sandstrom has produced evidence from which a reasonable trier of fact could conclude that cfs “intended” to establish an “informal” (which is to say, unwritten) severance-benefit plan and, if so, whether the terms of that plan are sufficiently definite to support a remedy. They debate, for example, whether Barton Finegan, the vice president of human resources who approved the offer to Velasco, had authority to establish a plan on behalf of Cfs. They also explore whether the Velasco offer sets out the terms of the plan or whether, instead, these terms may be found elsewhere — perhaps in a check sent to Velasco (which gave her one week’s pay in addition to what the offer *797 promised) or perhaps in the (written) plan for employees Cfs inherited from Pfizer. This plan had a 13-week base plus triple the week’s-pay-per-prior-year if the employee signed a release. Nor can the parties agree on whether the “informal plan” afforded benefits in lieu of notice (so that an employee who remained on the payroll after notice of termination would have severance benefits reduced by the number of weeks of employment yet to go) or was on top of whatever wages the employee earned. If cfs created a plan by making an offer to Velasco, did it amend or abolish the plan by not making a similar offer to Sandstrom? These are enigmas, which exemplify a deeper problem that the parties have not mentioned: does emsa contemplate unwritten plans? None of these uncertainties would exist if the plan were on paper.
Several of our cases say that it is possible to have an unwritten pension or welfare-benefit plan under erisa, if the plan is “a ‘reality,’ which requires ... that the court be able to determine ‘whether from the surrounding circumstances a reasonable person could ascertain the intended benefits, beneficiaries, source of financing, and procedures for receiving benefits.’” James
v. National Business Systems, Inc.,
Written plans may be altered only in writing. Statements by plan administrators, side agreements and understandings, or even special offers made to many of a firm’s employees, do not change the contents of the plan applicable to other employees. See, e.g.,
Central States Pension Fund v. Gerber Truck Service, Inc.,
These decisions are fatal to Sandstrom’s position, for his claim must be that cfs
amended
its formal plan (the one applicable only to former Pfizer employees) by making the offer to Velasco. Yet that is not the means erisa contemplates for plan amendments. See
Curtiss-Wright Corp. v. Schoonejongen,
AFFIRMED.
